ProtoBioS

    Looking for:
read the story

Established:

2013

Employees:

9

Location:

Tallinn

Distinctiveness:

MVA technology for profiling of immune response, patented by Protobios, and for the development of unique disease biomarkers

Services:

Provision of immunoprofiling service for the development of new drug targets, better vaccines, novel therapeutic regimen according to the needs of the customers, directed to the EU and US markets

Areas of activity:

Development of applied solutions from MVA, marketing MVA services

Main clients:

Academic, clinical, and industrial partners in the EU and US